Integrity Advisory Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
1,511
+80
+6% +$81.7K 0.19% 73
2026
Q1
$1.32M Buy
1,431
+27
+2% +$27.4K 0.17% 73
2025
Q4
$1.51M Buy
1,404
+6
+0.4% +$5.74K 0.22% 62
2025
Q3
$1.07M Buy
+1,398
New +$1.04M 0.17% 65

Other funds holding LLY

Integrity Advisory Solutions's LLY Position: Q2 2026 in Review

Integrity Advisory Solutions increased its Eli Lilly (LLY) stake by 5.6% in Q2 2026, buying an estimated $81.7K and bringing the position to 1,511 shares worth $1.81M. The position accounts for 0.19% of the portfolio, ranked #73.

Integrity Advisory Solutions first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Integrity Advisory Solutions held 1,511 shares of Eli Lilly worth $1.81M as of Q2 2026.
  • Integrity Advisory Solutions bought 80 Eli Lilly shares in Q2 2026, an estimated $81.7K.
  • Eli Lilly made up 0.19% of Integrity Advisory Solutions's portfolio in Q2 2026, its #73 holding.
  • Integrity Advisory Solutions first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Integrity Advisory Solutions's 13F filing for Q2 2026, filed 31 Jul 2026.